Table 5.
Safety measures at post treatment decision (T1) and at 3-month follow-up (T2)
| Post-treatment decision (T1) |
3-month follow-up (T2) |
|||||
|---|---|---|---|---|---|---|
| Control | Intervention | SMD (95% CI) | Control | Intervention | SMD (95% CI) | |
| M (SD, N) | M (SD, N) | M (SD, N) | M (SD, N) | |||
| Internal State Scale | ||||||
| Perceived Conflict (/500) | 185 (102.44, 56) | 162.98 (115.68, 57) | 0.20 (−0.17, 0.57) | 166.59 (101.04, 44) | 155.26 (112.92, 38) | 0.11 (−0.33, 0.55) |
| Well Being (/300) | 95.18 (47.33, 56) | 102.46 (48.23, 57) | −0.15 (− 0.52, 0.22) | 119.09 (73.1, 44) | 134.21 (75.5, 38) | − 0.20 (− 0.64, 0.24) |
| Activation (/500) | 185.36 (105.76, 56) | 177.72 (140.98, 57) | 0.06 (−0.31, 0.43) | 161.59 (108.5, 44) | 186.58 (141.01, 38) | −0.20 (− 0.64, 0.24) |
| Depression (/200) | 90.71 (60.45, 56) | 82.81 (63.74, 57) | 0.13 (−0.25, 0.50) | 88.86 (63.91, 44) | 69.21 (58.79, 38) | 0.32 (−0.12, 0.76) |
| State-Trait Anxiety Inventory (20–80) | 50.67 (14.45, 55) | 47.08 (14.99, 57) | 0.24 (−0.13, 0.62) | 51.21 (15.65, 44) | 45.44 (15.12, 38) | 0.37 (−0.07, 0.82) |
SMD standardised mean difference